跳至主要内容
临床试验/NCT03435432
NCT03435432已完成不适用

Investigating the Molecular Mechanisms Underpinning Glucose Stimulated Release of Stored Enteral Lipid in Humans

University Health Network, Toronto1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2016年3月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
6
试验地点
1
主要终点
Blood lipid responses to glucose drink

研究概览

简要总结

During dietary fat absorption, the gut packages the majority of the fats into lipid particles that are secreted into blood circulation. The gut is also capable of storing a considerable amount of fats that can be released at a later time upon receiving certain stimulus signals. One of the signals is glucose ingestion. This protocol examines blood lipid responses to a glucose drink. Participants drink a fatty formula and 5 hours later drink either a glucose solution or water (as control), in one of two randomized study visits. Blood lipid levels are monitored throughout the study period.

详细描述

Participants are recruited after obtaining informed consent. They first have a high fat liquid formula. 5 hours later, they drink 50 grams of glucose in 50 ml of water in one visit and 50 ml of water in another. The 2 visits are randomized. Blood samples are taken before and after they drink the high fat liquid formula, and continued until 3 hours after they drink glucose or water. Lipid levels in the blood samples are measured in the lab.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Men and women, aged 18 to 60 years requiring endoscopy and duodenal biopsies for clinical indications, with no contraindications to the procedure, as judged by Dr. Bookman.
  • •Body mass index 20 to 27 kg/m2

排除标准

  • •Patients with active inflammatory bowel disease
  • •Patients with Celiac disease, exocrine pancreatic insufficiency or small bowel malabsorption
  • •Patients with active bowel malignancy
  • •Patients with diabetes mellitus or known/ suspected motility disorders of the gut
  • •Patients with decompensated liver disease
  • •Patients on ezetemibe or bile acid sequestrants
  • •Unstable cardiac or respiratory disease
  • •Any changes to medication in the preceding month.

研究组 & 干预措施

Glucose

Active Comparator

50 grams of glucose in 50 ml water

干预措施: Glucose (Dietary Supplement)

Water

Placebo Comparator

50 ml water

干预措施: Water (Dietary Supplement)

结局指标

主要结局

Blood lipid responses to glucose drink

时间窗: 8 hours

Blood lipid levels are measured after drinking a glucose solution

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验